| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |